Literature DB >> 33716979

Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Bunpei Ishizuka1,2.   

Abstract

Premature ovarian insufficiency (POI) occurs in at least 1% of all women and causes life-long health problems and psychological stress. Infertility caused by POI used to be considered absolute, with infertility treatment having little or no value. Generally, it has been thought that medicine can provide little service to these patients. The etiology of POI has been found to be genetic, chromosomal, and autoimmune. In addition, the increasing numbers of cancer survivors are candidates for iatrogenic POI, along with patients who have undergone ovarian surgery, especially laparoscopic surgery. Over 50 genes are known to be causally related to POI, and the disease course of some cases has been clarified, but in most cases, the genetic background remains unexplained, suggesting that more genes associated with the etiology of POI need to be discovered. Thus, in most cases, the genetic background of POI has not been clarified. Monosomy X is well known to manifest as Turner's syndrome and is associated with primary amenorrhea, but recent studies have shown that some women with numerical abnormalities of the X chromosome can have spontaneous menstruation up to their twenties and thirties, and some even conceive. Hormone replacement therapy (HRT) is recommended for women with POI from many perspectives. It alleviates vasomotor and genitourinary symptoms and prevents bone loss and cardiovascular disease. POI has been reported to reduce quality of life and life expectancy, and HRT may help improve both. Most of the problems that may occur with HRT in postmenopausal women do not apply to women with POI; thus, in POI, HRT should be considered physiological replacement of estrogen (+progesterone). This review describes some new approaches to infertility treatment in POI patients that may lead to new treatments for POI, along with the development of more sensitive markers of secondary/preantral follicles and genetic diagnosis.
Copyright © 2021 Ishizuka.

Entities:  

Keywords:  autoimmunity; cardiovascular disease; chromosomal abnormality; genetics; hormone replacement therapy (HRT); ovulation induction; premature ovarian insufficiency (POI); vasomotor symptoms

Mesh:

Year:  2021        PMID: 33716979      PMCID: PMC7949002          DOI: 10.3389/fendo.2021.626924

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  158 in total

1.  Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease.

Authors:  Emma M Jenkinson; Atteeq U Rehman; Tom Walsh; Jill Clayton-Smith; Kwanghyuk Lee; Robert J Morell; Meghan C Drummond; Shaheen N Khan; Muhammad Asif Naeem; Bushra Rauf; Neil Billington; Julie M Schultz; Jill E Urquhart; Ming K Lee; Andrew Berry; Neil A Hanley; Sarju Mehta; Deirdre Cilliers; Peter E Clayton; Helen Kingston; Miriam J Smith; Thomas T Warner; Graeme C Black; Dorothy Trump; Julian R E Davis; Wasim Ahmad; Suzanne M Leal; Sheikh Riazuddin; Mary-Claire King; Thomas B Friedman; William G Newman
Journal:  Am J Hum Genet       Date:  2013-03-28       Impact factor: 11.025

2.  A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients.

Authors:  Konstantinos Sfakianoudis; Mara Simopoulou; Nikolaos Nitsos; Anna Rapani; Agni Pantou; Terpsithea Vaxevanoglou; Georgia Kokkali; Michael Koutsilieris; Konstantinos Pantos
Journal:  Gynecol Obstet Invest       Date:  2018-08-22       Impact factor: 2.031

3.  Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.

Authors:  Riley Bove; Elizabeth Secor; Lori B Chibnik; Lisa L Barnes; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neurology       Date:  2013-12-11       Impact factor: 9.910

Review 4.  An update: spontaneous premature ovarian failure is not an early menopause.

Authors:  Lawrence M Nelson; Sharon N Covington; Robert W Rebar
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

5.  Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial.

Authors:  Massimo Tartagni; Ettore Cicinelli; Giovanni De Pergola; Maria Antonietta De Salvia; Cristina Lavopa; Giuseppe Loverro
Journal:  Fertil Steril       Date:  2007-01-29       Impact factor: 7.329

Review 6.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

7.  Myasthenia gravis and premature ovarian failure.

Authors:  Monique M Ryan; H Royden Jones
Journal:  Muscle Nerve       Date:  2004-08       Impact factor: 3.217

8.  Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure.

Authors:  Paula Leite-Silva; Aloísio Bedone; Aarão Mendes Pinto-Neto; José Vilton Costa; Lúcia Costa-Paiva
Journal:  Arch Gynecol Obstet       Date:  2008-12-23       Impact factor: 2.344

Review 9.  Gonadal damage from chemotherapy and radiotherapy.

Authors:  S Howell; S Shalet
Journal:  Endocrinol Metab Clin North Am       Date:  1998-12       Impact factor: 4.741

10.  Analysis of late-onset ovarian insufficiency after ovarian surgery: retrospective study with 75 patients of post-surgical ovarian insufficiency.

Authors:  Seido Takae; Kazuhiro Kawamura; Yorino Sato; Chie Nishijima; Nobuhito Yoshioka; Yodo Sugishita; Yuki Horage; Mamoru Tanaka; Bunpei Ishizuka; Nao Suzuki
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

View more
  13 in total

1.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNA-29a Improves Ovarian Function of Mice with Primary Ovarian Insufficiency by Targeting HMG-Box Transcription Factor/Wnt/β-Catenin Signaling.

Authors:  Tian Gao; Yi Cao; Min Hu; Ying Du
Journal:  Dis Markers       Date:  2022-07-02       Impact factor: 3.464

2.  Cell-free fat extract improves ovarian function and fertility in mice with premature ovarian insufficiency.

Authors:  Mengyu Liu; Dan Zhang; Xiaowei Zhou; Jingru Duan; Yanqin Hu; Wenjie Zhang; Qiang Liu; Bufang Xu; Aijun Zhang
Journal:  Stem Cell Res Ther       Date:  2022-07-16       Impact factor: 8.079

3.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway.

Authors:  Zhongkang Li; Mingle Zhang; Jiahua Zheng; Yanpeng Tian; Huihui Zhang; Yi Tan; Qian Li; Jingkun Zhang; Xianghua Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-12       Impact factor: 5.555

Review 4.  Fertility preservation techniques in cervical carcinoma.

Authors:  Erica Silvestris; Angelo Virgilio Paradiso; Carla Minoia; Antonella Daniele; Gennaro Cormio; Raffaele Tinelli; Stella D'Oronzo; Paola Cafforio; Vera Loizzi; Miriam Dellino
Journal:  Medicine (Baltimore)       Date:  2022-04-29       Impact factor: 1.817

5.  Live Birth Rate in Patients With Premature Ovarian Insufficiency During Long-Term Follow-Up Under Hormone Replacement With or Without Ovarian Stimulation.

Authors:  Bunpei Ishizuka; Masataka Furuya; Machiko Kimura; Eri Kamioka; Kazuhiro Kawamura
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-17       Impact factor: 5.555

Review 6.  Complementary and Alternative Medicine for Premature Ovarian Insufficiency: A Review of Utilization and Mechanisms.

Authors:  Yang Fu; Dan-Ni Ding; Ying Shen; Li-Yan Jia; Meng-Yu Yan; Wei Wei; Chang-Hong Song; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-01       Impact factor: 2.629

7.  Searching for female reproductive aging and longevity biomarkers.

Authors:  Svetlana Yureneva; Viktoriya Averkova; Denis Silachev; Andrey Donnikov; Alla Gavisova; Vladimir Serov; Gennady Sukhikh
Journal:  Aging (Albany NY)       Date:  2021-06-22       Impact factor: 5.682

8.  De novo assembly and transcriptome characterization: Novel insights into the mechanisms of primary ovarian cancer in Microtus fortis.

Authors:  Qi Hu; Mingyue Gao; Du Zhang; Bingfeng Leng; Junwen Wang; Qian Liu; Shuangyan He; Wenling Zhi; Zhijun Zhou
Journal:  Mol Med Rep       Date:  2021-12-27       Impact factor: 2.952

9.  Expression of FMRpolyG in Peripheral Blood Mononuclear Cells of Women with Fragile X Mental Retardation 1 Gene Premutation.

Authors:  Xuan Phuoc Nguyen; Adriana Vilkaite; Birgitta Messmer; Jens E Dietrich; Katrin Hinderhofer; Knut Schäkel; Thomas Strowitzki; Julia Rehnitz
Journal:  Genes (Basel)       Date:  2022-03-01       Impact factor: 4.096

10.  Qilin Pill Exerts Therapeutic Effect on Resection-Induced Premature Ovarian Insufficiency Rats by Inhibiting the MAPK and PI3K-AKT Signaling Pathways.

Authors:  Debao Li; Yuling Jia; Yiwen Hou; Dingshi Chen; Chiyang Zheng; Lifen Chen; Li Zhou; Zuyue Sun
Journal:  Drug Des Devel Ther       Date:  2021-07-30       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.